First human insulins prequalified

The first human insulins have been prequalified by WHO: fast-acting human insulin 100 IU/ml and intermediate-acting human insulin 100 IU/ml from Novo Nordisk A/S. The manufacturer of these newly prequalified products has recently addressed the thermostability of the products and updated the storage conditions to provide the option to store the products at temperatures up to 30˚C for four weeks before opening. These updated storage conditions for the prequalified products will greatly facilitate the use of these essential medicines under challenging temperature conditions where there is limited access to refrigeration in relevant low- and middle-income countries. 

• BT-DM001 - Insulin human - solution for injection, 100 IU/ml (vial) - Novo Nordisk A/S
   
• BT-DM002 - Insulin human - solution for injection, 100 IU/ml (cartridge) - Novo Nordisk A/S
   
• BT-DM003 - Intermediate-acting, insulin human - suspension for injection, 100 IU/ml (vial) - Novo Nordisk A/S
   
• BT-DM004 - Intermediate-acting, insulin human - suspension for injection, 100 IU/ml (cartridge) - Novo Nordisk A/S